Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 185736, 9 pages
Research Article

Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB

Department of Biomedical Sciences and CNR Institute of Neuroscience, University of Padova, 35131 Padova, Italy

Received 27 May 2015; Accepted 6 August 2015

Academic Editor: Sung-Hoon Kim

Copyright © 2015 Cristina Girardi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Alessandro Morotti, Giovanna Carrà, Cristina Panuzzo, Sabrina Crivellaro, Riccardo Taulli, Angelo Guerrasio, and Giuseppe Saglio, “Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias,” Advances in Hematology, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Daniele Ottaviani, Oriano Marin, Giorgio Arrigoni, Cinzia Franchin, Jordi Vilardell, Michele Sandre, Wenwen Li, David A. Parfitt, Lorenzo A. Pinna, Michael E. Cheetham, and Maria Ruzzene, “Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain,” Human Molecular Genetics, pp. ddw420, 2016. View at Publisher · View at Google Scholar
  • Jürgen Vahter, Kaido Viht, Asko Uri, and Erki Enkvist, “Oligo-aspartic acid conjugates with benzo[ c ][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2,” Bioorganic & Medicinal Chemistry, vol. 25, no. 7, pp. 2277–2284, 2017. View at Publisher · View at Google Scholar
  • Janeen Trembley, Betsy Kren, Md. Abedin, Rachel Vogel, Claire Cannon, Gretchen Unger, and Khalil Ahmed, “CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer,” Pharmaceuticals, vol. 10, no. 1, pp. 25, 2017. View at Publisher · View at Google Scholar
  • Mirosława Koronkiewicz, Zdzisław Chilmonczyk, Zygmunt Kazimerczuk, and Andrzej Orzeszko, “Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Eduardo Silva-Pavez, Paulina Villar, César Trigo, Esteban Caamaño, Ignacio Niechi, Pablo Pérez, Juan P. Muñoz, Francisco Aguayo, Verónica A. Burzio, Manuel Varas-Godoy, Ariel F. Castro, María I. Colombo, and Julio C. Tapia, “CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells,” Cell Death & Disease, vol. 10, no. 2, 2019. View at Publisher · View at Google Scholar